AzTrials
AzTrials

Intubation;DifficultNCT03271008

Comparison of the Vividtrac™ and Other Videolaryngoscopes in Clinical Practice

A study testing Direct laryngoscopy, Vividtrac videolaryngoscope and KingVision videolaryngoscope in people with Intubation;Difficult, run by University of Pecs at 1 site in Hungary.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Comparison of various videolaryngoscope devices (Vividtrac™ and KingVision™) and direct laryngoscopy with Macintosh blade regarding laryngoscopy time, intubation time, intubation success rate, percentage of visible glottic opening (POGO score) in elective and acute clinical anaesthesiology practice. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Intubation;Difficult
What is being tested?
Direct laryngoscopy, Vividtrac videolaryngoscope and KingVision videolaryngoscope
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteHungary
Study dates
1 Jan 2017to 1 Jul 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • written informed consent
  • over 18 years of age
  • elective intervention
  • no anticipated difficult airway or intubation
  • preoperative anaesthesia risk assessment by American Society of Anaesthesiologists (ASA) physical status classification: ASA grade I-II

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

Gábor Woth, MD PhD contact

+36703729231

glwoth@gmail.com

Dóra Keresztes, MD contact

+36303875837

keresztesdora87@gmail.com

Hungary1 site, 1 recruiting
  • University of Pécs, Dept. of Anaesthesia and Intensive Care

    Pécs, Baranya, 7622

    Dóra Keresztes, MD

    Gábor Woth, MD PhD

    Recruiting

Other trials in Hungary

About this study

Official title: Comparison of Necessary Time for Successful Intubation With the Vividtrac™ and KingVision™ Videolaryngoscopes and Macintosh Blade Direct Laryngoscopy in Clinical Practice

Comparison of various videolaryngoscope devices (Vividtrac™ and KingVision™) and direct laryngoscopy with Macintosh blade regarding laryngoscopy time, intubation time, intubation success rate, percentage of visible glottic opening (POGO score) in elective and acute clinical anaesthesiology practice.

Being tested
Direct laryngoscopy, Vividtrac videolaryngoscope, KingVision videolaryngoscope

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Direct laryngoscopyDevice

    During the induction of general anaesthesia, the first attempt to achieve a secured airway is carried out using a size 4 (or size 3 if necessary) Macintosh blade direct laryngoscope.

  • Vividtrac videolaryngoscopeDevice

    During the induction of general anaesthesia, the first attempt to achieve a secured airway is carried out using a Vividtrac videolaryngoscope connected to a tablet or smartphone.

  • KingVision videolaryngoscopeDevice

    During the induction of general anaesthesia, the first attempt to achieve a secured airway is carried out using a KingVision videolaryngoscope.

Study groups in NCT03271008
Study groupRoleWhat they receive
Macintosh laryngoscopyActive comparatorIn this group intubation attempt is carried out with a standard Macintosh (size 3 or 4) direct laryngoscopy blade.
Receives: Device: Direct laryngoscopy
KingVision videolaryngoscopeActive comparatorIn this group intubation attempt is carried out with KingVision videolaryngoscope with a channeled, disposable single-use blade.
Receives: Device: KingVision videolaryngoscope
VividTrac videolaryngoscopeActive comparatorIn this group intubation attempt is carried out with VividTrac Adult model using a smartphone or laptop running the VividVision proprietary software.
Receives: Device: Vividtrac videolaryngoscope

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intubation time

    Time necessary to secure airway during the induction of general anesthesia. Intubation time is measured from the point the airway device crosses the interdental line until the completion of intubation with insufflated cuffed endotracheal tube (secured airway).

    Measured: Measured once during the intubation attempt. Up to 120 seconds following the start of intubation attempt.

Secondary outcomes (4)
  1. Laryngoscopy time

    Time necessary to achieve best visualisation of the glottic opening.

    Measured: Registered once during the intubation attempt. Up to 120 seconds following the start of intubation attempt.

  2. Percentage of glottic opening (POGO) score

    The POGO score describes the best view of the glottic opening compared to the anatomical picture of the glottis. During direct laryngoscopy the investigator registers an approximate socre, while video laryngoscopy records are assessed by an independent investigator.

    Measured: Registered once during the intubation attempt. Up to 120 seconds following the start of intubation attempt.

  3. Tube insertion time

    Time necessary for the operator to insert the cuffed endotracheal tube inside the proximal part of the trachea through the glottic opening. Tube insertion time is measured after the investigator finished the search for the glottic opening, achieved best view and decided to insert the tube into the trachea until the cuff is inflated and the airway is secured.

    Measured: Registered once during the intubation attempt. Up to 120 seconds following the start of intubation attempt.

  4. Primary intubation attempt success rate

    All intubation attempts must be finished within 120 seconds or the investigator should give up the attempt and reoxygenize the patient before another attempt. If the investigator finished within the 120 seconds time frame we assess endotracheal tube position by capnography and auscultation. The attempt is regarded successful if the tube is in the right position and the airway is secured.

    Measured: Measured once after intubation. Up to 120 seconds following the start of intubation attempt.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Sep 2017
  2. Study start1 Jan 2017
  3. Primary completion1 Jul 2018 (estimated)
  4. Study completion1 Jul 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03271008
Sponsor's protocol ID
6328
Status last verified
Aug 2017
First submitted
11 May 2017
Last updated
1 Sep 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Rendeki S, Keresztes D, Woth G, Merei A, Rozanovic M, Rendeki M, Farkas J, Muhl D, Nagy B. Comparison of VividTrac(R), Airtraq(R), King Vision(R), Macintosh Laryngoscope and a Custom-Made Videolaryngoscope for difficult and normal airways in mannequins by novices. BMC Anesthesiol. 2017 May 26;17(1):68. doi: 10.1186/s12871-017-0362-y.

    PubMed 28549421

Questions about this trial

What is this clinical trial studying?

A study testing Direct laryngoscopy, Vividtrac videolaryngoscope and KingVision videolaryngoscope in people with Intubation;Difficult, run by University of Pecs at 1 site in Hungary.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Sep 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hungary. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Gábor Woth, MD PhD (+36703729231, glwoth@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intubation time (time frame: Measured once during the intubation attempt. Up to 120 seconds following the start of intubation attempt.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03271008, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in